| DRUG WATCH |
|
| Year : 2018 | Volume
: 50
| Issue : 3 | Page : 139-142 |
Etoricoxib-induced toxic epidermal necrolysis: A fatal case report
Sukalyan Saha Roy1, Shatavisa Mukherjee1, Nikhil Era1, Mala Mukherjee2
1 Department of Clinical and Experimental Pharmacology, Calcutta School of Tropical Medicine, Kolkata, West Bengal, India
2 Department of Pathology, MGM Medical College, Kishanganj, Bihar, India
Correspondence Address:
Shatavisa Mukherjee
Department of Clinical and Experimental Pharmacology, Calcutta School of Tropical Medicine, Kolkata - 700 073, West Bengal
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijp.IJP_39_17
Cyclooxygenase inhibitors were developed in the quest of enhanced analgesic efficacy devoid of gastric side effects. High usage of etoricoxib by prescription as well as self-administered routes has led to increasing reports of side effects and adverse reactions including dermatologic reactions in 0.1%–0.3% of cases. The present report enumerates a case of toxic epidermal necrolysis induced by etoricoxib.
[FULL TEXT] [PDF]*
|
